News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mirna Therapeutics, Inc. Appoints Clay B. Siegall, Ph.D., to its Board of Directors



1/30/2013 8:23:40 AM

Mirna Therapeutics, a biotechnology company focused on the development and commercialization of microRNA (miRNA) therapeutics, today announced the appointment of Clay B. Siegall, Ph.D., co-founder, President, Chief Executive Officer and Chairman of Board of Directors of Seattle Genetics, as an outside director to its board of directors.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES